(2S,5S)-1-{2-[(S)-3-(4-Hydroxy-phenyl)-2-mercapto-propionylamino]-acetyl}-5-o-tolyl-pyrrolidine-2-carboxylic acid

ID: ALA2115220

Chembl Id: CHEMBL2115220

PubChem CID: 10575198

Max Phase: Preclinical

Molecular Formula: C23H26N2O5S

Molecular Weight: 442.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccccc1[C@H]1CC[C@@H](C(=O)O)N1C(=O)CNC(=O)[C@@H](S)Cc1ccc(O)cc1

Standard InChI:  InChI=1S/C23H26N2O5S/c1-14-4-2-3-5-17(14)18-10-11-19(23(29)30)25(18)21(27)13-24-22(28)20(31)12-15-6-8-16(26)9-7-15/h2-9,18-20,26,31H,10-13H2,1H3,(H,24,28)(H,29,30)/t18-,19+,20+/m1/s1

Standard InChI Key:  ORFNPOYNWDWXEI-AABGKKOBSA-N

Associated Targets(non-human)

MME Neprilysin (341 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ace Angiotensin-converting enzyme (1080 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ace Angiotensin-converting enzyme (91 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mme Neprilysin (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 442.54Molecular Weight (Monoisotopic): 442.1562AlogP: 2.47#Rotatable Bonds: 7
Polar Surface Area: 106.94Molecular Species: ACIDHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.91CX Basic pKa: CX LogP: 2.85CX LogD: -0.36
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.49Np Likeness Score: -0.22

References

1. Fournie-Zaluski MC, Coric P, Thery V, Gonzalez W, Meudal H, Turcaud S, Michel JB, Roques BP..  (1996)  Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.,  39  (13): [PMID:8691458] [10.1021/jm950783c]

Source